Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSX:CPH)

Fundamentals Snapshot (TSX:CPH)

Bullboard Posts (TSX:CPH)

RE:RE:RE:RE:RE:Q1

last 4 years revenues are stable, despite declining licensing next two years probably similar, sales down a bit perhaps they will do...
Northforce13 - June 1, 2022

RE:RE:RE:RE:Q1

Thanks for the response. What do you think about Absorica revenue declining? They can't survive on Epuris alone forever.
DrewJackson - June 1, 2022

RE:RE:RE:Q1

They don't need to do anything The share price is up > 50% from a year ago Often doing nothing is better than doing something...
Northforce13 - May 31, 2022

RE:RE:Q1

They're definitely looking at acquisitions. Their last press release on May 12, 2022 mentioned the following under the outlook ...
DrewJackson - May 24, 2022

RE:Q1

I really hope they are not looking at acquisitions.  I agree on their dismal record in this regard.  But, if they were to...
GJS471 - May 16, 2022

RE:Q1

They also have CF-101 results expected in Q2 2022. $0 debt. $21.9M cash. Monthly NCIB share buybacks. MOB-015 is a long way out...
DrewJackson - May 16, 2022